GRAS Notices
-
GRN No. 1114
Bifidobacterium breve DSM 33444
Intended Use: | Intended for use as an ingredient in non-exempt infant formula for term infants at a level up to 1.0 x 108 colony forming units (CFU)/g, as well as in conventional foods at levels up to 5.0 x 109 CFU/g. |
---|---|
Basis: | Scientific procedures |
Notifier: | Chr. Hansen A/S |
Notifier Address: |
Boege Allé 10-12 2970 Hoersholm Denmark |
GRAS Notice (releasable information): | GRN 1114 with amendments (in PDF) (4.7 MB) |
Date of closure: | Jul 10, 2023 |
FDA's Letter: | FDA has no questions (in PDF) (141 kB) |
-